Injective (INJ) is currently priced at $3.10, reflecting a modest 24-hour change of 2.27%. The daily range has been tight, with a high of $3.16 and a low of $3.02, indicating limited volatility in the short term.

Trading volume stands at approximately $47.97 million, contributing to a volume-to-market cap ratio of 15.48%. This suggests a healthy trading environment, though the relatively low daily range indicates that traders may be cautious, awaiting clearer market signals.

Examining the moving averages, the 8, 13, and 21-period SMAs are all below the current price, suggesting short-term bearish momentum. Conversely, the 55 SMA at $3.04 and the 144 SMA at $2.95 show positive trends of 2.04% and 5.19%, respectively, indicating potential support levels.

The RSI metrics reveal mixed signals; the 1-hour RSI is neutral at 49, while the 7-day RSI at 57 indicates slight bullish momentum. The recent 7-day price change of 7.80% suggests a recovery from previous lows, but the 14-day change remains flat, pointing to consolidation over a longer period.

Overall, while INJ shows signs of a minor recovery and maintains support from longer-term moving averages, the lack of significant upward momentum and mixed RSI readings indicate uncertainty. Given these factors, the recommendation is to Hold INJ, as it may be prudent to wait for clearer bullish indicators or a breakout above recent resistance levels before committing further capital.